Preetam Shah, EVP, CFO and Treasurer at BRAINSTORM CELL THERAPEUTICS INC. (BCLI), bought 11,600 shares at $3.96 ($46K) on 2019-12-24, disclosed to the SEC on 2019-12-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CDTX | SELL | 2022-09-19 | $12K | — | Filing → |
| CDTX | BUY | 2021-11-15 | $31K | — | Filing → |